Bon Secours St. Francis Cancer Center

Greenville, South Carolina 29607

2 studies enrolling now · 9 studies all time

What they study most

Acute Myeloid Leukemia, Advanced Cancer, Bladder Cancer, Breast Tumor, Colon Tumor, Malignant, Early Breast Cancer, Endometrial Cancer, Esophageal Cancer, Head and Neck Cancer, Hematologic Malignancies, Hematologic Malignancy, Locally Advanced Solid Tumor

Studies at this site

• Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML — Recruiting now
• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors — Stopped early
• Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2 — Running, not enrolling
• Clinical Effectiveness Assessment of VeriStrat® Testing and Validation of Immunotherapy Tests in NSCLC Subjects — Running, not enrolling
• CMP-001 in Combination With Pembrolizumab in Subjects With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — Stopped early
• Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML — Stopped early
• Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) — Completed
• Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies — Stopped early